🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8735126

Disease control with tick phospholipase A2

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735082

Gene signature for predicting prognosis of patients with solid tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8728488

Methods of inducing an immune response in a host by administering flavivirus immunogens co

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8722653

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8716301

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8715686

Conformationally stabilized HIV envelope immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710026

MiR 204, miR 211, their anti-miRs, and therapeutic uses of same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8709813

DNA promoters and anthrax vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703921

Compositions and methods for delivering inhibitory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8703150

Methods of using Bacillus anthracis protective antigen sequences for vaccination

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697046

Methods of administering interferon gamma to absorb fluid from the subretinal space

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697666

Anti-cancer oligodeoxynucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8686016

Schweinfurthins and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685722

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685416

Compositions and methods for the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685396

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680065

Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and m

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680056

Antiproliferative factor and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673333

Cross-linked polymer matrices, and methods of making and using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673316

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664183

SPANX-B polypeptides and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652787

Use of ERBB4 as a prognostic and therapeutic marker for melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647818

Molecular scaffolds for HIV-1 immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted